IP Verse

Wilding patent opposition analysis

The comprehensive analysis of Wilding opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Wilding

Stay updated with the latest patent oppositions filed by Wilding

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP3645553	Tropism-Modified Recombinant Viral Particles And Uses Thereof For The Targeted Introduction Of Genetic Material Into Human Cells	REGENERON PHARMACEUTICALS	Dec 14, 2023	JG OPPOSITIONS
EP3549601	Non-Lipidated Variants Of Neisseria Meningitidis Orf2086 Antigens	WYETH	Nov 23, 2021	JG OPPOSITIONS
EP3616720	Pharmaceutical Composition For Cancer Treatment	SHIONOGI	Nov 16, 2021	ABBVIE
EP3099333	Bag3 As A Target For Therapy Of Heart Failure	TEMPLE UNIVERSITY OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION	Aug 18, 2021	JG OPPOSITIONS
EP3252160	Crispr-Cas Component Systems, Methods And Compositions For Sequence Manipulation	PRESIDENT AND FELLOWS OF HARVARD COLLEGE	Jul 28, 2021	JG OPPOSITIONS
EP2976101	Method Of Treatment	GLAXOSMITHKLINE	May 18, 2021	SANOFI PASTEUR
EP2349332	Methods And Compositions For Regulating Iron Homeostasis By Modulation Bmp-6	THE GENERAL HOSPITAL	Jul 23, 2020	MATHYS & SQUIRE
EP3011032	Delivery, Engineering And Optimization Of Systems, Methods And Compositions For Targeting And Modeling Diseases And Disorders Of Post Mitotic Cells	THE BROAD INSTITUTE	Jul 16, 2020	MATHYS & SQUIRE
EP3360964	Crispr-Based Genome Modification And Regulation	SIGMA ALDRICH	Jul 2, 2020	MATHYS & SQUIRE
EP3011034	Delivery, Use And Therapeutic Applications Of The Crispr-Cas Systems And Compositions For Targeting Disorders And Diseases Using Viral Components	PRESIDENT AND FELLOWS OF HARVARD COLLEGE	May 7, 2020	MATHYS & SQUIRE

Top clients of Wilding

Top companies who are the clients of Wilding

Company	Total
MATHYS & SQUIRE	22
JG OPPOSITIONS	7
ABBVIE	2
SANOFI PASTEUR	2